{"url_path":"/sec/mlab/10-k/2026/item-12","section_key":"item-12","section_title":"Item 12 Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/724004/0000724004-26-000047-index.html","accession_number":"0000724004-26-000047","cik":"0000724004","ticker":"MLAB","issuer_name":"MESA LABORATORIES INC /CO/","edgar_url":"https://www.sec.gov/Archives/edgar/data/724004/0000724004-26-000047-index.html","primary_entity_key":"0000724004","primary_entity_name":"MESA LABORATORIES INC /CO/"},"word_count":287,"has_tables":true,"body_markdown":"**Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters**\n\n \n\n***Securities Authorized for Issuance Under Equity Compensation Plans***\n\n \n\nThe following table presents information regarding options and rights outstanding under our equity compensation plans as of March 31, 2026. All options reflected are options to purchase common stock.\n\n \n\n \n \n**(a) Number of Securities to be Issued upon Exercising of Outstanding Options and Rights (1)**\n \n \n**(b) Weighted-Average Exercise Price of Outstanding Options and Rights (1)**\n \n \n**(c) Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (excluding securities reflected in column (a)) (2)**\n \n\nEquity Compensation Plan Approved by Security Holders\n \n \n619,480\n \n \n$\n191.22\n \n \n \n536,520\n \n\nEquity Compensation Plans Not Approved by Security Holders\n \n \nNone\n \n \n \nN/A\n \n \n \nNone\n \n\nTotal\n \n \n619,480\n \n \n$\n191.22\n \n \n \n536,520\n \n\n \n\n \n\n1.\n\nIncludes shares issuable in connection with awards with performance conditions, which will be issued based on achievement of performance criteria associated with the awards, with the number of shares issuable dependent on our level of performance. We have accounted for the shares based on actual achievement, if known, or based on maximum possible achievement if performance and/or market conditions remain uncertain as of March 31, 2026. The weighted average exercise price in column (b) includes the weighted average exercise price of options only.\n\n \n\n2.\n\nConsists of 536,520 shares remaining available under the 2021 Equity Plan. Each share underlying a full value award such as restricted stock or performance shares count as one share used against the total number of securities authorized under the plan.\n\n \n\nAdditional information for this item is incorporated by reference from the definitive Proxy Statement for our 2026 Annual Meeting of Stockholders or an amendment to this report to be filed no later than 120 days after March 31, 2026."}